Immunonutrition in surgery and critical care.
The benefits of specialty supplemented enteral diets administered to critically ill and critically injured patients and those undergoing major surgical procedures have been documented in a number of randomized prospective studies. It is unclear which nutrient or combination of nutrients causes the beneficial effects, but there are significant reductions in infectious complications depending upon the patient populations studied. It is imperative that the data be interpreted in the context of individual patient risk since specialty formulas appear most beneficial in patients at risk of subsequent complications or in those with significant pre-existing malnutrition. Although controversy exists regarding the use of specialty supplemented enteral diets in critically ill patients, they have been administered safely with minimal risk of adverse outcome in malnourished patients and in the critically ill and critically injured.
Kudsk
Kenneth A
KA
Department of Surgery, College of Medicine, University of Wisconsin, Madison, Wisconsin 53792-7375, USA. kudsk@surgery.wisc.edu
D000597:Amino Acids, Branched-Chain / Q000008:administration & dosage; D001120:Arginine / Q000008:administration & dosage; D003422:Critical Care; D016638:Critical Illness / Q000628:therapy*; D004750:Enteral Nutrition; D019317:Evidence-Based Medicine; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D005526:Food, Formulated; D005973:Glutamine / Q000008:administration & dosage; D006801:Humans; D007113:Immunity, Innate; D009711:Nucleotides / Q000008:administration & dosage; D016896:Treatment Outcome
D000597:Amino Acids, Branched-Chain; D015525:Fatty Acids, Omega-3; D009711:Nucleotides; D005973:Glutamine; D001120:Arginine